We are in the business of helping scientists connect with contract research organizations (CROs) and research providers, and we see a wide spectrum...
This is Part 3 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...
Breast cancer has an enormous amount of funding and awareness, as it affects millions of woman worldwide. With the recent hubbub around Angelina...
This week, we are pleased to announce that the CIO Magazine has recognized Scientist efforts in using information technology to transform drug...
Just last week, we wrote about how drug development costs are keeping obesity drugs off the market. This week, we take a look at Alzheimer’s...
We’ve covered the importance of tactical vs strategic outsourcing and the potential for savings and innovation by outsourcing, and now we’ll be...
Obesity has been linked to cancer, heart disease, high blood pressure, diabetes, and stroke. As a common underlying factor in so many preventable...
In the past 10 years, we’ve experienced a shift: the move from in-person to virtual interactions. Email, Facebook, Twitter, and a slew of other...
More than 366 million people are living with diabetes, according to the International Diabetes Federation. Diabetes has associated health risks...
This is Part 2 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...
Search
Categories
- Artificial Intelligence (5)
- Challenges (63)
- Discovery & Innovation (195)
- Industry Trends (210)
- Infographics (17)
- News & Events (87)
- Open Science (39)
- Outsourcing (73)
- Press Releases (145)
- Research Exchanges (58)
- Research Services (96)
- Scientist In The News (152)
- Supplier Spotlight (50)
- Tech Snapshot (37)
- Webinars (34)